
Chemomab Therapeutics Ltd.
NASDAQCMMB utilization hits 91.83%, near its 52-week peak of 100%, as short sellers face tight borrow supply.
Snapshot as of 29 Jun 2026
No long-form analysis yet for CMMB. Pulse alerts and the live data picture are available on ORTEX.
Open CMMB on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CMMB — free to start on ORTEX.
Sign up for free →Open CMMB on ORTEX